ProBioGen and Life Technologies Present Freedom<sup>TM</sup> CHO-S<sup>TM</sup> Platform, a Royalty-Free New cGMP Cell Line Development Kit
16 May 2011
ProBioGen AG and Life Technologies Corporation announce the launch of the new Freedom™ CHO-S™ Kit as the result of a successful co-development. The kit was built for developing stable high yield production cell lines in less than 4 months, and is based on Life Technologies’ CHO-S™ Cells. The Freedom™ CHO-S™ Kit platform enables end-users the cost- and time-efficient creation of stable cell lines for research and commercial purposes. The kit’s applicability and efficiency was confirmed in several studies, in which antibody titers of 1 to 3 g/L have been obtained.
The Freedom™ CHO-S™ Kit, sold by Life Technologies, includes all major components to complete the cell line development work flow: cGMP banked CHO-S™ cells, a cloning vector for two genes, transfection reagent, competent cells, serum-free cell culture media and reagents. With this kit it is possible to go from transfection to lead clone in less than 4 months. Research use rights are granted upon kit purchase.
A full documentation package is provided as part of a commercial use license. The package includes the cell line’s lineage as well as the history and the parental cGMP testing results.